Sales: $146 million for personal care products. Corporate sales: $4.1 billion.
Key Personnel: Michael O. Johnson, chairman and chief executive officer; Desmond Walsh, president; John G DeSimone, chief financial officer; Mr. Richard P. Goudis, chief operating officer; Mr. Brett R. Chapman, chief legal officer and secretary.
Major Products: Personal care products fall under the major brand names such as Skin Activator, Herbal Aloe, Radiant C and NouriFusion.
Comments: Although its personal care products shrank slightly from last year, Herbalife posted record corporate results, as sales rose 18% on a 20% increase in volume compared to 2011. Of its corporate sales, the Asia-Pacific region continued to represent the highest percentage of its sales at 25.4%. North America represented 24.5%, South and Central America was 15.7%, Mexico was 17.3% EMEA represented 12.8% and China was 4.4%.
In June, Herbalife announced results of a study on distributors and end users and found that 3.3% of US adults (7.9 million) have purchased Herbalife products for personal use within the past three months. Weight Management is the most commonly purchased type of Herbalife product for personal use, with 95% of recent (past three month) Herbalife customers claiming to have bought this product.
“This survey, conducted by one of the world’s most respected research organizations, confirms what we at Herbalife already know to be true: that Herbalife’s products have a broad consumer base here in the US—nearly 8 million in the last three months—and that the majority of individuals that purchase Herbalife products do so for personal consumption,” stated Michael O. Johnson, Herbalife’s chairman and CEO.
During the past six months, Herbalife has become a major focus in the media after billionaire hedge fund investor William Ackman began shorting Herbalife’s stock. Ackman has called Herbalife a “pyramid scheme” and has been betting heavily that its stock would fall.
At press time, however, most investors appear to be siding with Carl Icahn, a major shareholder of Herbalife who has two of his representatives on the company’s board of directors and is a long-time rival of Ackman. Icahn is long on Herbalife and the stock has nearly doubled since hitting its 52-week low of $24.24 in November.